glp-1 prescriptions growth slowing 2024 Receptor Agonist Market Size GLP-1 RA prescription trends: January

Across randomized cardiovascular outcome trials and meta-analyses, SGLT2 inhibitors consistently reduce hospitalization for heart failure by approximately 3037% (hazard ratio [HR] 0.630.70), with benefits observed regardless of prior atherosclerotic cardiovascular disease status [6, 23]

These are usually felt for up to 2-3 days after the treatment

(The Demographics) Based on NPR investigation and online communities: Athletes (professional and amateur) Faster injury recovery Performance edge Willing to risk ban Biohackers and longevity seekers Anti-aging obsession "Optimize everything" mentality Follow influencers blindly Bodybuilders and fitness enthusiasts Muscle growth Fat loss Recovery between workouts People with chronic injuries Desperate for healing Failed conventional treatments Willing to try experimental options Gut health patients IBS, Crohn's, ulcerative colitis Leaky gut No FDA-approved options work Common thread: Desperation or optimization obsession, combined with aggressive online marketing

These medications work by mimicking hormones that regulate appetite and blood sugar